Blue Star Foods Corp. (BSFC): Nasdaq/NYSE listing notice — Blue Star Foods receives Nasdaq delisting notice; appeals and shareholders approve reverse split

Blue Star Foods Corp.

Nasdaq notified Blue Star on May 17, 2023 it failed to meet minimum bid price requirement and is ineligible for a second 180-day cure period.
Company requested a hearing before Nasdaq Hearings Panel on May 22, 2023, which stays any suspension or delisting pending final decision.
Stockholders approved a reverse stock split on May 10, 2023 at a ratio from 1:2 to 1:50 to regain compliance with the bid price rule.
If no appeal, common stock would be suspended at the open on May 26, 2023.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Blue Star Foods Corp. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 17, 2023, Blue Star Foods Corp. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has not regained compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for continued listing on The Nasdaq Capital Market and is not eligible for a second 180 day period to regain compliance with the Minimum Bid Price Requirement. Accordingly, unless the Company timely requests an appeal of this determination before the Nasdaq Hearings Pa

View on SEC.gov

Browse all listing & compliance notices →

Blue Star Foods Corp. filing history →

Source: SEC EDGAR

accession 0001493152-23-018594

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.